Clinical

Dataset Information

0

Evaluation of a brain training programme in cancer survivors self reporting cognitive changes


ABSTRACT: Interventions: A home based, computerised cognitive rehabilitation programme to be used for 4x forty-minute sessions per week for a total of 15 weeks (i.e. 40 hours). There are five training exercises that form the core of the program, each targeting a different area of brain functioning. These cognitive targets include visual precision, divided attention, working memory, useful field of view and visual processing speed. Each exercise has an accompanying assessment that sets an improvement goal and measures progress against that goal. The exercises adapt to an individual’s performance and all patients will complete a recommended schedule of training as per the programme design. Primary outcome(s): The primary endpoint is self reported cognitive function as assessed by the Functional Assessment of Cancer Therapy - Cognitive Function (FACT-COG). The primary outcome will be the difference between the intervention group and the control group in the change in FACT-COG score on completion of the cognitive rehabilitation program compared to the baseline score.[Self reported cognitive function as measured by FACT-COG will be evaluated at 3 time points. These assessments will be at baseline, on completion of the 15 week intervention and 6 months following completion of the intervention.] Study Design: Purpose: Treatment; Allocation: Randomised controlled trial; Assignment: Parallel;Type of endpoint: Safety/efficacy

DISEASE(S): Cancer-bowel-back Passage (rectum) Or Large Bowel (colon),Cancer-ovarian And Primary Peritoneal,Cognitive Impairment In Cancer Survivors,Cancer-breast

PROVIDER: 2455008 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2471038 | ecrin-mdr-crc
| 2018622 | ecrin-mdr-crc
2017-07-13 | ST000814 | MetabolomicsWorkbench
| 2701435 | ecrin-mdr-crc
| 2423555 | ecrin-mdr-crc
2016-09-21 | GSE79683 | GEO
2017-08-31 | GSE45462 | GEO
| 2470262 | ecrin-mdr-crc
| 2472945 | ecrin-mdr-crc
2024-01-03 | GSE243471 | GEO